Strata Critical Medical, Inc.
SRTA
$4.34
$0.040.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 181.59% | 65.40% | 50.89% | 54.79% | -31.83% |
| Total Depreciation and Amortization | 35.25% | -26.45% | -32.14% | -34.14% | -31.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -375.39% | -59.92% | -12.86% | -26.60% | 11,677.59% |
| Change in Net Operating Assets | 154.96% | -175.94% | 180.12% | 20.66% | -246.08% |
| Cash from Operations | -319.94% | 108.97% | 141.19% | 92.21% | 68.61% |
| Capital Expenditure | 27.08% | 46.32% | -925.23% | -922.38% | -711.21% |
| Sale of Property, Plant, and Equipment | -44.93% | -44.93% | -91.30% | -94.93% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 445.66% | 180.79% | 12.03% | 74.11% | 25.66% |
| Cash from Investing | 1,227.94% | 761.04% | -120.38% | -105.95% | -128.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 52.50% | -8.53% | 17.76% | 124.29% | 73.91% |
| Repurchase of Common Stock | -765.61% | -614.56% | -9,168.63% | -3,451.37% | -963.11% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -478.83% | -744.29% | -201,280.00% | -7,477.63% | -3,500.00% |
| Foreign Exchange rate Adjustments | -2,388.89% | 241.18% | 110.53% | -115.15% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 109.54% | 389.76% | 58.81% | 39.14% | -14.67% |